Pennantpark Floating Rate Capital Ltd. quarterly report, Q1 FY2021

Business Context and Reporting Period

PennantPark Floating Rate Capital Ltd. (PFLT) is a closed-end, externally managed Business Development Company (BDC) and Regulated Investment Company (RIC) focused on investing in floating-rate loans to U.S. middle-market companies. This Form 10-Q covers the quarterly period ended March 31, 2021, and the six-month period ended on the same date. The company operates with a strategy to generate current income and capital appreciation while preserving capital, primarily through first-lien secured debt.

Key Financial Metrics

Metric Three Months Ended Mar 31, 2021 Six Months Ended Mar 31, 2021 Six Months Ended Mar 31, 2020
Total Investment Income $19.4 million $40.2 million $51.0 million
Net Investment Income $9.9 million $20.0 million $22.9 million
Net Increase in Net Assets from Operations $11.7 million $37.8 million ($11.1 million)
Net Asset Value (NAV) per Share $12.71 $12.71 $12.12
Total Assets $1.14 billion $1.14 billion $1.15 billion
Total Liabilities $645.6 million $645.6 million $671.0 million
Cash and Cash Equivalents $66.6 million $66.6 million $57.5 million
Weighted Average Debt Outstanding N/A $600.8 million $720.4 million
Asset Coverage Ratio 182% 182% 168%

Material Changes vs. Prior Period

  • Operational Performance: The company reported a net increase in net assets of $37.8 million for the six months ended March 31, 2021, a significant improvement from a net decrease of $11.1 million in the same period in 2020. This turnaround was primarily driven by unrealized gains in the equity co-investment program, specifically related to ITC Rumba, LLC (Cano Health, LLC).
  • Investment Income: Total investment income decreased to $40.2 million for the six months ended March 31, 2021, compared to $51.0 million in the prior year. Management attributed this decline to a reduction in portfolio size and lower LIBOR rates.
  • Expense Reduction: Total expenses decreased to $20.1 million for the six months ended March 31, 2021, from $28.1 million in the prior year. This reduction was driven by lower management fees and decreased debt-related interest and expenses.
  • Debt Structure: In March 2021, the company issued $100.0 million of 4.25% Notes due 2026. Additionally, the Credit Facility capacity was reduced from $520 million to $400 million in January 2021. Outstanding borrowings under the Credit Facility decreased from $308.6 million at September 30, 2020, to $146.9 million at March 31, 2021.
  • Portfolio Composition: As of March 31, 2021, the portfolio consisted of 100 companies with a weighted average yield on debt investments of 7.6%. The portfolio had net unrealized appreciation of $4.7 million, reversing the net unrealized depreciation of $29.9 million reported at September 30, 2020.

Guidance, Outlook, Risks, and Unusual Items

  • Outlook and Strategy: Management continues to focus on investing in floating-rate loans to U.S. middle-market companies. The company maintains a diversified portfolio with 98% of debt investments being variable-rate. The company intends to continue making monthly distributions to stockholders.
  • COVID-19 Impact: The filing highlights that the ongoing pandemic creates uncertainty regarding the financial health of portfolio companies. While two portfolio companies were on non-accrual status as of March 31, 2021 (representing 2.3% of the portfolio by fair value), management anticipates potential future defaults or restructuring needs due to economic disruptions.
  • Interest Rate Risk: The company is sensitive to changes in interest rates. A 1% increase in interest rates is projected to increase net interest income by approximately $4.7 million annually, while a 1% decrease would reduce it by approximately $0.5 million. The company did not engage in interest rate hedging activities during the period.
  • Leverage and Asset Coverage: The company operates under a 150% asset coverage ratio requirement (reduced from 200% in 2019). As of March 31, 2021, the ratio was 182%, providing a buffer for additional borrowing if market conditions allow.
  • Unusual Items: The significant unrealized gains in the equity co-investment program were a primary driver of the positive net change in net assets, contrasting with the prior year's performance.

Investor Verification Checklist

  • Non-Accrual Status: Verify the specific identities and financial status of the two portfolio companies currently on non-accrual status and their impact on future cash flows.
  • Equity Co-Investment Valuation: Review the valuation methodology and underlying assumptions for the equity co-investments (e.g., Cano Health) that drove the significant unrealized gains.
  • Debt Maturity Profile: Assess the upcoming maturity schedule for the 2023 Notes (installments due annually) and the 2026 Notes to understand refinancing risks.
  • LIBOR Transition: Monitor the company's strategy regarding the transition from LIBOR to alternative risk-free rates, given that 98% of the debt portfolio is variable-rate.
  • Distribution Sustainability: Analyze the relationship between Net Investment Income and declared distributions to determine if distributions are fully covered by earnings or if a return of capital is likely.